X.-G. Li et al. / Tetrahedron: Asymmetry 19 (2008) 1857–1861
1861
MS: m/z (relative intensity) 242 (0.24), 222 (15), 164 (5), 146 (6),
106 (100), 79 (13), 43 (6); 1H NMR (500 MHz, CDCl3) d 0.95 (d,
3H, J = 6.5 Hz, CH3), 1.08 (d, 3H, J = 6.5 Hz, CH3), 2.00 (br s, 2H,
NH2), 3.97 (m, 1H, CH (CH3)2), 4.59 (t, 1H, J = 13.5 Hz, CHNH2),
6.04 (br s, 1H, NHCO), 7.31–7.38 (m, 5 arom. H); 13C NMR
(126 MHz, CDCl3) d 22.07 (CH3), 22.19 (CH3), 41.62 (CH(CH3)2),
57.87 (t, J = 23.9 Hz, CHNH2), 116.35 (t, J = 258.3 Hz, CF2), 128.03,
128.50, 128.54, 136.26 (arom. C), 162.61 (t, J = 28.9 Hz, CO); 19F
128.15, 128.40, 128.55, 129.17, 136.10, 137.35, 154.67, 165.77 (d,
J = 18.9 Hz), 170.55.
4.8. Preparation of b-dipeptide 12
Lipase PS-D (60 mg mLꢀ1) was added to a solution of (R)-3b
(31 mg, 0.13 mmol, ee = 99%) and (R)-6 (40 mg, 0.25 mmol,
ee = 99%) in dry DIPE (2.5 mL) and was stirred at 57 °C for 48 h be-
fore the work-up as above, except that ethyl acetate in petroleum
ether (1:3, v/v) was used as an eluent to afford dipeptide 12
NMR (471 MHz, CDCl3)
ꢀ117.38 (dd, J = 247.0, 11.8 Hz).
d
ꢀ116.39 (dd, J = 247.0, 14.1 Hz),
{43 mg, 0.11 mmol, mp 140–141 °C, ½a D22
¼ þ32:4 (c 1.05, CHCl3)}
ꢁ
in 82% yield; HRMS: M+ found (M+ calculated for C22H34N2O5)
406.247800 (406.246773); MS: m/z (relative intensity) 406 (8),
294 (65), 249 (36), 119 (62), 106 (74), 57 (100); 1H NMR
(500 MHz, CDCl3) d 0.97 (d, J = 6.5 Hz, 3H), 1.42 (s, 18H), 2.28 (d,
J = 5.5 Hz, 2H), 2.54 (dd, J = 14.0 Hz, 5.5 Hz, 1H), 2.68 (m, 1H),
4.19 (m, 1H), 5.01 (m, 1H), 6.03 (d, J = 8.0 Hz, 1H), 6.26 (br s, 1H),
7.20–7.35 (m, 5H).
4.5. Preparation of b-dipeptide 9
Lipase PS-D (40 mg mLꢀ1) was added to a solution of (S)-1a
(16 mg, 0.08 mmol, ee = 99%) and (R)-6 (24 mg, 0.15 mmol,
ee = 99%) in dry DIPE (1.5 mL). The reaction was stopped after
15 h by filtering off the enzyme. The solid part was washed with
dichloromethane (4 mL) and the filtrate was concentrated under
vacuum. The residue was purified on silica gel eluting with ethyl
acetate in petroleum ether (1:1, v/v) to afford dipeptide
9
4.9. Non-enzymatic preparation of b-dipeptide 13
{25 mg, 0.07 mmol, mp 100–101 °C, ½a D22
¼ þ28:8 (c 1.00, CHCl3)}
ꢁ
in 96% yield; HRMS: M+ found (M+ calculated for C17H24F2N2O3)
342.174300 (342.175499); MS: m/z (relative intensity) 342 (0.7),
285 (4), 191 (7), 106 (100); 1H NMR (500 MHz, CDCl3) d 1.13 (d,
J = 6.5 Hz, 3H, CH3CH), 1.42 (s, 9H, (CH3)3), 2.12 (dd, J = 15.8 Hz,
5.5 Hz, 1H, CH2), 2.27 (dd, J = 15.8 Hz, 4.5 Hz, 1H, CH2), 4.19 (m,
1H, CH), 4.60 (m, 1H, CH), 7.05 (d, J = 8.0 Hz, 1H, CONH), 7.32–
7.40 (m, 5H).
Solution of (S)-3b (25 mg, 0.10 mmol, ee = 99%) and (S)-7
(47 mg, 0.20 mmol, ee = 99%) in dry DIPE (2.0 mL) was stirred
for 144 h, before the work-up as above, except that ethyl acetate
in petroleum ether (1:4, v/v) was used as an eluent to afford
dipeptide 13 (31 mg, 0.07 mmol, mp 139–140 °C, ½a D22
¼ ꢀ15.0
ꢁ
(c 1.00, CHCl3)) in 65% yield; HRMS: M+ found (M+ calculated
for C28H38N2O5) 482.278300 (482.278073); MS: m/z (relative
intensity) 482 (4), 409 (13), 353 (15), 279 (20), 192 (60), 88
(100); 1H NMR (500 MHz, CDCl3) d 1.42 (s, 9H), 1.43 (s, 9H),
2.17 (dd, J = 16.0 Hz, 5.5 Hz, 1H), 2.26 (dd, J = 16.0 Hz, 5.5 Hz,
1H), 2.53 (m, 2H), 2.69 (m, 2H), 4.33 (m, 1H), 5.04 (m, 1H),
6.98–7.33 (m, 10H).
4.6. Preparation of b-dipeptide 10
Lipase PS-D (40 mg mLꢀ1) was added to the solution of (3S,4S)-
2a (30 mg, 0.18 mmol, ee = 99%) and (R)-6 (58 mg, 0.36 mmol,
ee = 99%) in dry DIPE (3.6 mL). After 18 h, the reaction was worked
up as above to afford the gum-like dipeptide 10 (30 mg,
0.09 mmol) in 51% yield. In order to facilitate the characterization,
the free amino group of 10 was protected in the quantitative yield
in the presence of Boc2O (2 equiv) and NEt3 (2.5 equiv) in dry
dichloromethane. The data for N-Boc-protected 10 are as follows.
Acknowledgment
This work was supported by the Academy of Finland (Grant No.
109743 to L.K.)
½
a 2D2
ꢁ
¼ þ4:2 (c 0.75, CHCl3); HRMS: M+ found (M+ calculated for
References
C22H33FN2O5) 424.236800 (424.237351); MS: m/z (relative inten-
sity) 424 (0.5), 295 (32), 206 (43), 191 (24), 150 (81), 106 (77),
57 (100); 1H NMR (500 MHz, CDCl3) d 1.09 (d, J = 7.0 Hz, 3H),
1.38 (s, 9H), 1.43 (s, 9H), 1.66 (m, 1H), 2.10 (dd, J = 15.5 Hz,
4.0 Hz, 1H), 4.09 (m, 1H), 5.22 (d, J = 51.5 Hz, 1H), 5.26 (m, 1H),
7.27–7.33 (m, 5H).
1. Patrick, G. L. An Introduction to Medicinal Chemistry, 3rd ed.; Oxford University
Press, 2005. pp 391–393.
2. Palomo, C.; Aizpurua, J. M.; Ganboa, I.; Oiarbide, M. In Enantioselective Synthesis
of b-Amino Acids; Juriasti, E., Soloshonok, V., Eds., 2nd ed.; Wiley-VHC: New
York, 2005; p 477.
3. Palomo, C.; Aizpurua, J. M.; Ganboa, I.; Oiarbide, M. Synlett 2001, 1813–1826.
4. Palomo, C.; Aizpurua, J. M.; Ganboa, I.; Oiarbide, M. Eur. J. Org. Chem. 1999,
3223–3235.
5. Benaglia, M.; Cinquini, M.; Cozzi, F. Eur. J. Org. Chem. 2000, 563–572.
6. Li, X.-G.; Kanerva, L. T. Org. Lett. 2006, 8, 5593–5596.
4.7. Non-enzymatic preparation of b-dipeptide 11
7. Sundholm, O.; Kanerva, L. T. J. Chem. Soc., Perkin Trans. 1 1993, 2407–2410.
8. Brieva, R.; Crich, J. Z.; Sih, C. J. J. Org. Chem. 1993, 58, 1068–1075.
9. (a) Li, X.-G.; Lähitie, M.; Päiviö, M.; Kanerva, L. T. Tetrahedron: Asymmetry 2007,
18, 1567–1573; (b) Li, X.-G.; Kanerva, L. T. Adv. Synth. Catal. 2006, 348, 197–205.
10. Forró, E.; Fülöp, F. Mini-Rev. Org. Chem. 2004, 1, 93–102.
11. Liljeblad, A.; Kanerva, L. T. Tetrahedron 2006, 62, 5831–5854.
12. Seebach, D.; Beck, A. K.; Bierbaum, D. J. Chem. Biodivers. 2004, 1, 1111–1239.
13. Heck, T.; Kohler, H.-P. E.; Limbach, M.; Flogel, O.; Seebach, D.; Geueke, B. Chem.
Biodivers. 2007, 4, 2016–2030.
14. Li, X.-G.; Kanerva, L. T. Tetrahedron: Asymmetry 2007, 18, 2468–2472.
15. Gedey, S.; Liljeblad, A.; Fülöp, F.; Kanerva, L. T. Tetrahedron: Asymmetry 1999,
10, 2573–2581.
16. Hu, J.; Miller, M. J. J. Am. Chem. Soc. 1997, 119, 3462–3468.
17. Ericsson, D. J.; Kasrayan, A.; Johansson, P.; Bergfors, T.; Sandström, A. G.;
Bäckvall, J.-E.; Mowbray, S. L. J. Mol. Biol. 2008, 376, 109–119.
18. Kanerva, L. T.; Csomós, P.; Sundholm, O.; Bernáth, G.; Fülöp, F. Tetrahedron:
Asymmetry 1996, 7, 1705–1716.
(S)-7 (38 mg, 0.16 mmol, ee = 99%) was added to a solution of
(3R,4R)-2b (21 mg, 0.08 mmol, ee = 99%) in dry DIPE (1.6 mL).
The reaction was worked up after 24 h as above except that ethyl
acetate in petroleum ether (1:8, v/v) was used as an eluent to
afford solid 11 {39 mg, 0.08 mmol, mp 136–137 °C, ½a D22
¼ þ8:7
ꢁ
(c 1.00, CHCl3)} in 97% yield; HRMS: M+ found (M+ calculated for
C28H37FN2O5) 500.270000 (500.268651); MS: m/z (relative inten-
sity) 500 (1), 409 (11), 297 (35), 191 (46), 106 (55), 88 (86), 57
(100); 1H NMR (500 MHz, CDCl3) d 1.43 (s, 18H), 1.64 (m, 1H),
2.04 (dd, J = 16.0 Hz, 4.0 Hz, 1H), 2.74 (m, 2H), 4.21 (m, 1H), 5.19
(d, J = 50.1 Hz, 1H), 5.23 (m, 1H), 7.08–7.27 (m, 10H); 13C NMR
(126 MHz, CDCl3) d 28.11, 28.32, 37.23, 39.32, 46.37, 55.98 (d,
J = 17.6 Hz), 80.15, 81.34, 92.75 (d, J = 194.9 Hz), 126.70, 127.93,